Our Featured Services
Make confident investment and launch decisions with our Market Sizing & Opportunity Assessment service—built to help pharma and life sciences companies quantify value, identify white spaces, and prioritize growth opportunities. We combine top-down and bottom-up approaches, leveraging epidemiology, treatment
dynamics, regulatory insights, and competitive intelligence to provide a clear, data-driven view of the commercial potential across indications, geographies, and patient segments.
What We Offer:
- TAM, SAM, and SOM estimations with scenario-based forecasting
- Epidemiological modeling and treatment rate analysis
- Patient flow mapping and unmet need identification
- Segmentation by region, payer mix, and prescriber behavior
- Opportunity scoring and prioritization frameworks
- Custom market models, dashboards, and executive-ready summaries
Whether you're evaluating a pipeline asset, entering a new market, or planning a portfolio strategy, our insights help you align resources with the highest-impact opportunities. See the size of the prize—then build the strategy to win it.
Forecast with precision—whether you're planning for a future launch or optimizing an existing brand—with our Pipeline & In-line Forecasting service. We help pharma and life sciences companies build dynamic, evidence-based forecasts across the product lifecycle to support strategic decision-making, resource
allocation, and investor confidence. Our models are built from the ground up, integrating epidemiology, clinical trial outcomes, market dynamics, competitive landscapes, access scenarios, and adoption curves to generate accurate and adaptable forecasts.
What We Offer:
- Revenue forecasting for pipeline and marketed assets
- Epidemiology-based patient modeling by indication and geography
- Market share simulations under competitive and pricing scenarios
- Adoption curve modeling based on analogs and market behavior
- Risk-adjusted forecasts incorporating regulatory and clinical milestones
- Custom Excel models, dashboards, and validation workshops
Ideal for commercial, finance, portfolio, and BD teams, this service supports everything from go/no-go decisions to long-term planning and investor communication. From early pipeline to peak sales—our forecasting helps you plan with confidence and clarity
Support smarter deal-making with our BD&L Forecasting service—designed to help pharmaceutical and biotech companies accurately assess the commercial potential of in-licensing and out-licensing opportunities. We develop rigorous, risk-adjusted forecasts that integrate market dynamics,
clinical viability, competitive landscape, and access considerations—giving you a clear, objective view of asset value. Whether you're evaluating a single product or an entire portfolio, our insights enable better negotiations and investment decisions.
What We Offer:
- Asset-level revenue forecasts across key markets and indications
- Deal scenario modeling (upfronts, milestones, royalties, profit shares)
- Epidemiology and patient-based opportunity assessment
- Risk-adjusted NPV and ROI modeling
- Comparable deal benchmarking and valuation support
- Customizable Excel forecast models and executive summaries
Ideal for BD&L, corporate strategy, and investment teams, this service strengthens your ability to evaluate, negotiate, and justify deals with confidence. Make every deal decision count—with forecasts that are grounded, transparent, and strategic.
Harness the power of artificial intelligence to transform your pharmaceutical forecasting with our cutting-edge AI-Powered Pharma Forecasting Tool...
Our tool integrates vast datasets—including epidemiology, clinical outcomes, market dynamics, and competitive intelligence—and applies advanced machine learning algorithms...
Key Features:
- Dynamic, real-time forecasting with adaptive learning
- Scenario simulation for market access, pricing, and competitive shifts
- Risk-adjusted revenue projections
- Customizable dashboards and visualization tools
- Seamless integration with your existing platforms
Ideal for commercial teams... Empower your forecasting with AI—turn data into decisive action.